ABSI Absci Corp
Company Analysis
Latest News
🟢 Absci is trading 7% up today as it rebounds amid a broader market rally
Absci is trading 7% higher at $8.07, rebounding from recent dilution-related weakness as broader U.S. markets show strength. • The move appears aligned with a...
🔴 Absci is trading 5.2% down today as it extends a pullback from its recent parabolic rally
Absci is trading at $7.65 (down 5.2%) as it extends a pullback following a parabolic rally and a sharp drop in last Thursday’s extended session. • The recent...
🔴 Absci is trading 5.2% down today as it extends a sharp selloff amid broader biotech weakness
Absci is trading 5.2% down at $7.80 as it extends a sharp selloff from the July 16 session amid broader biotech weakness. • The move follows a 16.5% drop on...
🔴 Absci is trading 10.2% down
Absci is trading at $8.77, down 10.2% from a comparison close of $9.76 during regular trading. This is a price-action follow-up, so a separate catalyst may not...
🔴 Absci is trading 6.7% down today, extending a multi-day slide on profit-taking
Absci is trading 6.7% down at $9.10, extending a multi-day slide as investors continue to lock in gains following a massive rally earlier in 2026. • The stock...
🟢 Absci is trading 5.6% up today on AI pipeline optimism and analyst support
Absci is trading 5.6% up at $11.72 as momentum continues for its AI-designed drug discovery pipeline and positive analyst sentiment. • Wall Street analysts...
🔴 ABSI extends move to 6.1% down
ABSI is trading at $10.63, down 6.1% versus the comparison close of $11.33 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 ABSI is trading 5% down today as biotech sector weakens amid broader risk-off sentiment
ABSI is trading at $10.76 (-5.03%) as the stock gives back recent gains while biotech shares weaken amid broader risk-off market sentiment. • No fresh...
🔴 ABSI is trading 5.6% down today amid broader risk-off sentiment in biotech
ABSI is trading 5.6% down at $10.70 in pre-market, pulling back after a strong run over the past week. • The move appears aligned with broader market weakness...
🟢 ABSI is trading 5% up today amid ongoing AI-driven rally momentum
ABSI is trading 5% up now at $11.67 as the stock extends its recent AI-driven run, following sharp gains since late June tied to optimism around its AI-enabled...
🔴 ABSI is trading 5% down today on profit-taking after a sharp multi-day AI-driven rally
ABSI is trading 5% down at $11.01 as the stock undergoes consolidation following a significant multi-day run-up. • The pullback follows a period of intense...
🟢 ABSI is trading 5.2% up today on bullish analyst coverage and AI platform optimism
ABSI is trading at $11.46 (5.2% up) following a multi-day rally driven by bullish analyst coverage and growing optimism surrounding its AI-driven biopharma...
🟢 ABSI makes sharp 11.0% jump
ABSI is trading at $11.33, up 11.0% versus the comparison close of $10.21 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 ABSI is trading 8% up today after HC Wainwright price target hike and Eli Lilly-backed deal
ABSI is trading 8% up at $11.03 as the stock extends its sharp multi-day rally following a $100 million Eli Lilly-backed equity offering and positive clinical...
🟢 ABSI surges 6.6% today after Eli Lilly-backed $100M stock offering and positive ABS-201 trial data
ABSI is trading 6.6% up today at $10.74, extending a rally driven by positive interim Phase 1 data for its ABS-201 hair loss and endometriosis therapy and...
🟢 ABSI is trading 5.8% up today after $100M Eli Lilly-backed stock offering
ABSI is trading 5.8% up at $10.66 in pre-market action following strong demand for a $100 million underwritten stock offering. • The offering, priced at $7.41...
Absci Prices $100 Million Stock Offering with Participation from Eli Lilly
Absci Corporation announced the pricing of an underwritten public offering of 13,495,277 shares of its common stock at $7.41 per share. The company expects to...
🟢 ABSI is trading 44% up today after positive Phase 1 data for AI-designed hair-loss drug and $100M offering
ABSI is trading 44% up today at $10.68 after reporting positive interim Phase 1 safety data for its AI-designed hair-loss antibody, ABS-201, and announcing a...
Absci's AI-Designed Hair-Loss Drug Clears an Early Safety Hurdle — But Can a $1 Billion Bet Survive the Long Road to Approval?
Shares of Absci Corp surged nearly 20% in pre-market trading to $8.88 after the company reported positive interim Phase 1 data for its lead hair-loss drug...
🟢 ABSI is trading 19.9% up today after positive Phase 1 hair-loss data
ABSI is trading at $8.88 (19.9%) up today after releasing positive interim Phase 1 data for its hair-loss antibody ABS-201. • The company reported favorable...